PORTAGE, Mich. – Stryker today announced the launch of Synchfix™ EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.
Commonly associated with sports trauma and ankle fractures, ankle syndesmotic injuries can significantly affect patient mobility and recovery. Synchfix EVT builds on the legacy Synchfix platform, incorporating design enhancements that reduce procedural complexity compared to the predicate device.
Synchfix EVT features an all-in-one system that integrates suture tensioning handles within the implant instrumentation, along with a handle design for one-handed surgical implant deployment. The device is engineered to provide a seamless user experience with an ergonomic handle and a low-profile titanium medial implant.
Synchfix™ EVT is intended for soft tissue and bone fixation for ankle syndesmosis disruptions with or without ankle fractures and as an adjunct in connection with hardware for ankle fractures such as Weber B, Weber C and Maisonneuve in adult and adolescent patient populations. Notably, it is the first ankle syndesmotic flexible fixation device on the market indicated for use in adolescents, expanding treatment options for younger patients.
The system has also been recognized with the prestigious Red Dot Design Award, honoring its innovative, all-in-one implant and instrumentation designed to simplify syndesmotic fixation and enhance surgical efficiency compared to the previous generation of the device.
